Literature DB >> 2330105

The relationship of age to outcome in myasthenia gravis.

D H Donaldson1, M Ansher, S Horan, R B Rutherford, S P Ringel.   

Abstract

This study, a retrospective review of 165 patients with myasthenia gravis, compares the course of the disease for patients with onset before 50 and at or after 50. There were no significant differences between age groups for presenting symptoms, but more of the older patients had progressed to severe disease. More of the younger than the older patients were in remission or were asymptomatic on medication at the last visit. Sixty-two percent of those treated with steroids developed complications, with a larger portion of these being in the older group. Cataracts, infection, and bone changes were particularly significant for the older population. Complications of azathioprine treatment and plasmapheresis were less common. Thymoma was more common in the older population; these patients did no worse than the population as a whole. Sixty-five percent of our patients have undergone thymectomy, most by a modified transsternal approach. A much larger portion of those who underwent thymectomy were in remission at the last visit than those who did not.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330105     DOI: 10.1212/wnl.40.5.786

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

2.  Mortality and survival in myasthenia gravis: a Danish population based study.

Authors:  P B Christensen; T S Jensen; I Tsiropoulos; T Sørensen; M Kjaer; E Højer-Pedersen; M J Rasmussen; E Lehfeldt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

3.  Thymectomy for Myasthenia Gravis.

Authors:  Gary S. Gronseth; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.598

Review 4.  A practical guide to the recognition and management of myasthenia gravis.

Authors:  A Evoli; A P Batocchi; P Tonali
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

5.  Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis.

Authors:  Seung Woo Kim; Young-Chul Choi; Seung Min Kim; Hyo Sup Shim; Ha Young Shin
Journal:  J Neurol       Date:  2019-02-06       Impact factor: 4.849

6.  Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

Authors:  Elena Cortés-Vicente; Rodrigo Álvarez-Velasco; Sonia Segovia; Carmen Paradas; Carlos Casasnovas; Antonio Guerrero-Sola; Julio Pardo; Alba Ramos-Fransi; Teresa Sevilla; Adolfo López de Munain; Maria Teresa Gómez; Ivonne Jericó; Gerardo Gutiérrez-Gutiérrez; Ana Lara Pelayo-Negro; María Asunción Martín; María Dolores Mendoza; Germán Morís; Ricard Rojas-Garcia; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Beatriz Vélez; María Antonia Albertí; Lucía Galán; Tania García-Sobrino; Alicia Martínez-Piñeiro; Ana Lozano-Veintimilla; Roberto Fernández-Torrón; Ángel Cano-Abascal; Isabel Illa
Journal:  Neurology       Date:  2020-02-18       Impact factor: 9.910

7.  Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.

Authors:  Hyun Seok Roh; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2011-01-17

Review 8.  Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.

Authors:  Yan Luo; Deng-Ji Pan; Fei-Fei Chen; Ming-Hui Zhu; Jing Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

9.  A population based epidemiological study on myasthenia gravis in Estonia.

Authors:  M Oöpik; A-E Kaasik; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

10.  Racial differences in myasthenia gravis in Alabama.

Authors:  Shin J Oh; Marla B Morgan; Liang Lu; Yuki Hatanaka; Shoji Hemmi; Angela Young; Gwendolyn C Claussen
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.